GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
10.59
+5.72 (117.45%)
At close: Sep 12, 2025, 4:00 PM EDT
8.80
-1.79 (-16.90%)
After-hours: Sep 12, 2025, 7:59 PM EDT
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $9.52 million as of September 12, 2025. Its market cap has decreased by -35.84% in one year.
Market Cap
9.52M
Enterprise Value
236.75K
1-Year Change
-35.84%
Ranking
Category
Stock Price
$10.59
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $9.52M, a decrease of -72.09%. That is a compound annual growth rate of -9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 9.52M | 59.09% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |